INTEGRA Biosciences’ Pipettes Help Clinics to Tackle the Opioid Epidemic

September 12, 2023 10:42 PM AEST | By EIN Presswire

Google News:

INTEGRA Biosciences’ Pipettes Help Clinics to Tackle the Opioid Epidemic — Image source: EIN Presswire

Recent News

SYDNEY BASED CBD INSIGHTS LIFESTYLE MAGAZINE COMMENCE FEATURES ON CARP...

At London Climate Week, forestry companies launch Natural Capital Valu...

Apple internally weighs bid for ChatGPT rival Perplexity, Bloomberg sa...

Fed Daly eyes fall for possible policy shift

UNITED KINGDOM, September 12, 2023/EINPresswire.com/ -- Axis Healthcare, a family-run care facility in Oklahoma, has introduced VOYAGER adjustable tip spacing pipettes from INTEGRA Biosciences into its PCR laboratory workflows. These multichannel pipettes offer the laboratory a straightforward and easy-to-use liquid handling solution to provide accurate and high throughput testing as part of a holistic strategy to support patients in overcoming opioid addiction.

Axis Healthcare offers services ranging from primary care and pain management to dermatology and behavioral health, but the ongoing opioid epidemic in the United States means that the laboratory receives high numbers of samples to be tested each week. Daniel Bergner, General Supervisor of the laboratory at Axis Healthcare, explained how VOYAGER adjustable tip spacing pipettes boost productivity in the PCR laboratory: “Our laboratory is multifaceted. In addition to toxicology testing, we offer PCR assays for COVID-19, as well as testing for urinary tract infections and a variety of other conditions. The VOYAGER adjustable tip spacing pipettes are a key part of our PCR workflows, maximizing our productivity as we face immense pressure and testing demands.”

“During the pandemic, point-of-care testing escalated quickly. INTEGRA’s multichannel pipetting solutions allowed us to quickly increase our capacity, and they continue to boost our testing capabilities today. The electronically adjustable tip spacing simplifies sample reformatting, allowing us to transfer multiple samples between labware of different formats in a single step. We can perform complex analyses – such as liquid chromatography-mass spectrometry (LC-MS), drug confirmations and PCR – in high volumes, and have absolute confidence in what we are doing because of the accuracy and precision of the pipettes. As we look to the future, we may begin using the pipettes in our toxicology laboratory in addition to our PCR laboratory. We know that we can rely on INTEGRA to provide ongoing assistance and further automation as needed, helping us to keep supporting patients in their battle against opioid addiction,” Daniel concluded.

Visit the INTEGRA Biosciences website to learn more.

About INTEGRA Biosciences

INTEGRA Biosciences (https://www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.

© 2023 kdm communications limited

Emily Armiger-Welch
kdm communications limited
+44 1480 405333
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.